Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum: an entero-bone endocrine axis

Loss- and gain-of-function mutations in the broadly expressed gene Lrp5 affect bone formation causing osteoporosis and high bone mass, respectively. Although Lrp5 is viewed as a Wnt coreceptor osteoblast-specific disruption of β-Catenin does not affect bone formation. Instead, we show here that Lrp5...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yadav, Vijay K., Ryu, Je-Hwang, Suda, Nina, Tanaka, Kenji, Gingrich, Jay A., Schütz, Günther, Glorieux, Francis H., Chiang, Cherie Y., Zajac, Jeffrey D, Insogna, Karl L., Mann, J. John, Hen, Rene, Ducy, Patricia, Karsenty, Gerard
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2614332/
https://ncbi.nlm.nih.gov/pubmed/19041748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2008.09.059
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares